0001193125-23-039351.txt : 20230214 0001193125-23-039351.hdr.sgml : 20230214 20230214170713 ACCESSION NUMBER: 0001193125-23-039351 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230208 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230214 DATE AS OF CHANGE: 20230214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CONTRAFECT Corp CENTRAL INDEX KEY: 0001478069 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36577 FILM NUMBER: 23631349 BUSINESS ADDRESS: STREET 1: 28 WELLS AVENUE STREET 2: 3RD FLOOR CITY: YONKERS STATE: NY ZIP: 10701 BUSINESS PHONE: 914-207-2300 MAIL ADDRESS: STREET 1: 28 WELLS AVENUE STREET 2: 3RD FLOOR CITY: YONKERS STATE: NY ZIP: 10701 8-K 1 d464805d8k.htm 8-K 8-K
CONTRAFECT Corp NASDAQ false 0001478069 --12-31 0001478069 2023-02-08 2023-02-08

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 8, 2023

 

 

ContraFect Corporation

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-36577   39-2072586
(State or other jurisdiction
of incorporation)		   (Commission
File Number)		   (IRS Employer
Identification Number)

28 Wells Avenue, 3rd Floor, Yonkers, New York 10701

(Address of principal executive offices) (Zip Code)

(914) 207-2300

Registrant’s telephone number, including area code

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading
Symbol(s)

  

Name of each exchange
on which registered

Common Stock, $0.0001 par value per share   CFRX   Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

As previously disclosed, on January 20, 2023, the staff (“Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) informed ContraFect Corporation (the “Company”) that the Staff had determined to deny the Company’s request for continued listing on the Nasdaq Capital Market (the “Staff Determination”) in connection with its failure to satisfy the continued listing requirement under Nasdaq Listing Rule 5550(b)(1) for the Nasdaq Capital Market. The Company subsequently requested a hearing before a Nasdaq Hearings Panel (“Panel”) to appeal the Staff Determination, which was granted and is scheduled to occur in March 2023.

In addition, on August 25, 2022, the Staff notified the Company that the bid price of its common stock had closed at less than $1 per share over the previous 30 consecutive business days, and, as a result, did not comply with the continued listing requirement under Nasdaq Listing Rule 5550(a)(2) to maintain a bid price for the Company’s common stock of above $1.00 per share (the “Bid Price Requirement”).

On February 8, 2023, the Staff notified the Company that the Staff had determined that, as of February 7, 2023, the Company’s common stock had a closing bid price of $0.10 or less for ten consecutive trading days and that, consistent with Nasdaq Listing Rule 5810(c)(3)(A)(iii) (the “Low Priced Stocks Rule”), the Staff was providing notice of an additional and separate basis to delist the Company’s securities from the Nasdaq Capital Market for failure to comply with the Low Priced Stocks Rule relating to the Bid Price Requirement.

The Panel will consider this matter in rendering its determination regarding the Company’s continued listing on the Nasdaq Capital Market.

The Company believes that the 1-for-80 reverse stock split of its common stock that became effective at 5:00 p.m. ET on February 14, 2023, as described in Item 5.03 herein, will enable the Company to cure its non-compliance with the Bid Price Requirement and Low Priced Stocks Rule.

The Company continues to evaluate various alternative courses of action to regain compliance with the continued listing requirement under Nasdaq Listing Rule 5550(b)(1) for the Nasdaq Capital Market. However, there can be no assurance that the Company will be able to satisfy the Nasdaq Capital Market’s continued listing requirements, regain compliance with Nasdaq Listing Rule 5550(b)(1), the Bid Price Requirement or the Low Priced Stocks Rule, or maintain compliance with the other Nasdaq continued listing requirements.

Forward-Looking Statements

This current report contains “forward-looking statements” within the meaning of the U.S. federal securities laws. Forward-looking statements can be identified by words such as “projects,” “may,” “will,” “could,” “would,” “should,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “potential,” “promise” or similar references to future periods. Examples of forward-looking statements in this current report include, without limitation, statements regarding the Panel’s consideration of this matter in making its determination as to the Company’s continued listing on the Nasdaq Capital Market, the Company’s expectation that the 1-for-80 reverse stock split will enable the Company to comply with the Bid Price Requirement and the Low Priced Stocks Rule, the Company’s intent or ability to regain or maintain compliance with Nasdaq Listing Rule 5550(b)(1), the outcome of the Panel’s review of the Company’s appeal of the Staff Determination, and any courses of action to regain compliance with the Nasdaq Capital Market’s continued listing requirements. Forward-looking statements are statements that are not historical facts, nor assurances of future performance. Instead, they are based on the Company’s current beliefs, expectations and assumptions regarding the future of its business, future plans, strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent risks and uncertainties, and actual results may differ materially from those set forth in the forward-looking statements. Important factors that could cause actual results to differ include, without limitation, there can be no assurance that the Company will meet the stockholders’ equity requirement, the Bid Price Requirement or the Low Price Stocks Rule during any compliance period or otherwise in the future, otherwise meet Nasdaq compliance standards, that Nasdaq will grant the Company any relief from delisting as necessary or whether the Company can agree to or ultimately meet applicable Nasdaq requirements for any such relief, that the Company has and expects to continue to incur significant losses, the Company’s need for additional funding, which may not be available, the occurrence of any adverse events related to the discovery,

development and commercialization of the Company’s product candidates such as unfavorable clinical trial results, insufficient supplies of drug products, lack of regulatory approval, or unsuccessful attainment or maintenance of patent protection, and the other important factors described under the caption “Risk Factors” in the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) on November 14, 2022 and its other filings with the SEC. Any forward-looking statement made by the Company in this current report is based only on information currently available and speaks only as of the date on which it is made. Except as required by applicable law, the Company expressly disclaims any obligation to publicly update any forward-looking statements, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

As previously reported in its Current Report on Form 8-K filed with the Securities and Exchange Commission on February 2, 2023, ContraFect Corporation (the “Company”) held a Special Meeting of Stockholders on January 31, 2023 (the “Special Meeting”), which was adjourned to February 10, 2023, solely with respect to the proposal to approve amendments to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company’s common stock as described in the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on January 3, 2023. At the reconvened Special Meeting held on February 10, 2023 (the “Reconvened Special Meeting”), the Company’s stockholders voted to approve an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of the Company’s common stock at a ratio ranging from any whole number between 1-for-10 and 1-for-80, as determined by the Board of Directors in its discretion, subject to the Board of Directors’ authority to abandon such amendments. The Company’s Board of Directors determined to abandon all of the amendments other than the ratio of 1-for-80.

At 5:00 p.m., Eastern Time, on February 14, 2023 (the “Effective Time”), a Certificate of Amendment to Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) became effective that implemented the reverse stock split of the Company’s common stock at a ratio of 1-for-80 (the “Reverse Stock Split”). The Reverse Stock Split did not change the par value of the Company’s common stock. Consequently, at the Effective Time, every eighty (80) shares of the Company’s issued common stock automatically combined into one issued share of the Company’s common stock. At the opening of trading on February 15, 2023, the Company expects its common stock will begin trading on a split-adjusted basis on The Nasdaq Capital Market under the symbol “CFRX” and under a new CUSIP number 212326409.

The foregoing description of the Certificate of Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Certificate of Amendment, which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 5.07. Submission of Matters to a Vote of Security Holders.

The information in Item 5.03 is incorporated herein by reference. At the Reconvened Special Meeting, the Company’s stockholders voted to approve the amendment to the Company’s Amended and Restated Certificate of Incorporation to effect the Reverse Stock Split by a vote of 22,790,007 shares of common stock for, 4,386,014 shares of common stock against and 29,058 shares of common stock abstaining. There were no broker non-votes in connection with this proposal.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit
No.		   

Description

3.1    Certificate of Amendment of Amended and Restated Certificate of Incorporation of ContraFect Corporation, dated February 14, 2023.
104    Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    CONTRAFECT CORPORATION
Date: February 14, 2023     By:  

  /s/ Natalie Bogdanos

        Natalie Bogdanos
        General Counsel and Corporate Secretary
 EX-3.1 2 d464805dex31.htm EX-3.1 EX-3.1

Exhibit 3.1

CERTIFICATE OF AMENDMENT

OF

AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

OF

CONTRAFECT CORPORATION

ContraFect Corporation, a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “Corporation”), does hereby certify as follows:

 

FIRST:    That, at a meeting of the Board of Directors of the Corporation, resolutions were duly adopted recommending and declaring advisable that the Amended and Restated Certificate of Incorporation of the Corporation be amended and that such amendments be submitted to the stockholders of the Corporation for their consideration, as follows:
   RESOLVED, that the first paragraph of Article FOURTH of the Amended and Restated Certificate of Incorporation of the Corporation, as amended and/or restated to date, be amended and restated in its entirety to read as follows:
  

“That, effective as of 5 p.m. Eastern Time on the date this Certificate of Amendment of Amended and Restated Certificate of Incorporation is filed with the Office of the Secretary of State of the State of Delaware (the “Effective Time”), a one-for-eighty reverse stock split of the Corporation’s Common Stock (as defined below) shall become effective, pursuant to which each eighty shares of Common Stock outstanding and held of record by each stockholder of the Corporation (including treasury shares) immediately prior to the Effective Time shall be reclassified and combined into one validly issued, fully-paid and nonassessable share of Common Stock automatically and without any action by the holder thereof upon the Effective Time and shall represent one share of Common Stock from and after the Effective Time (such reclassification and combination of shares, the “Reverse Stock Split”). The par value of the Common Stock following the Reverse Stock Split shall remain at $0.0001 per share. No fractional shares of Common Stock shall be issued as a result of the Reverse Stock Split. In lieu thereof, (i) with respect to holders of one or more certificates which formerly represented shares of Common Stock that were issued and outstanding immediately prior to the Effective Time, upon surrender after the Effective Time of such certificate or certificates, any holder who would otherwise be entitled to a fractional share of Common Stock as a result of the Reverse Stock Split, following the Effective Time, shall be entitled to receive a cash payment (the “Fractional Share Payment”) equal to the fraction of which such holder would otherwise be entitled multiplied by the closing price per share as reported by The Nasdaq Capital Market (as adjusted to give effect to the Reverse Stock Split) on the date of the Effective Time; provided that, whether or not fractional shares would be issuable as a result of the Reverse Stock Split shall be determined on the basis of (a) the total number of shares of Common Stock that were issued and outstanding immediately prior to the Effective Time formerly represented by certificates that the holder is at the time surrendering and (b) the aggregate number of shares of Common Stock after the Effective Time into which the shares of Common Stock formerly represented by such certificates shall have been reclassified; and (ii) with respect to holders of shares of Common Stock in book-entry form in the records of the Company’s transfer agent that were issued and outstanding immediately prior to the Effective Time, any holder who would otherwise be entitled to a fractional share of Common Stock as a result of the Reverse Stock Split, following the Effective Time, shall be entitled to receive the Fractional Share Payment automatically and without any action by the holder.”

SECOND:    That, at a special meeting of stockholders of the Corporation, the aforesaid amendment was duly adopted by the stockholders of the Corporation.
THIRD:    That, the aforesaid amendment was duly adopted in accordance with the applicable provisions of Section 242 of the General Corporation Law of the State of Delaware.

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed by its President and Chief Executive Officer on this 14th day of February, 2023.

 

CONTRAFECT CORPORATION
By:   /s/ Roger J. Pomerantz
  Roger J. Pomerantz, M.D., F.A.C.P.
  President and Chief Executive Officer
 EX-101.SCH 3 cfrx-20230208.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 4 cfrx-20230208_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Entity Registrant Name Entity Registrant Name Security Exchange Name Security Exchange Name Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Document Type Document Type Document Period End Date Document Period End Date Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 5 cfrx-20230208_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Document and Entity Information
Feb. 08, 2023
Cover [Abstract]  
Entity Registrant Name CONTRAFECT Corp
Security Exchange Name NASDAQ
Amendment Flag false
Entity Central Index Key 0001478069
Current Fiscal Year End Date --12-31
Document Type 8-K
Document Period End Date Feb. 08, 2023
Entity Incorporation State Country Code DE
Entity File Number 001-36577
Entity Tax Identification Number 39-2072586
Entity Address, Address Line One 28 Wells Avenue
Entity Address, Address Line Two 3rd Floor
Entity Address, City or Town Yonkers
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10701
City Area Code (914)
Local Phone Number 207-2300
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.0001 par value per share
Trading Symbol CFRX
Entity Emerging Growth Company false
XML 7 d464805d8k_htm.xml IDEA: XBRL DOCUMENT 0001478069 2023-02-08 2023-02-08 CONTRAFECT Corp NASDAQ false 0001478069 --12-31 8-K 2023-02-08 DE 001-36577 39-2072586 28 Wells Avenue 3rd Floor Yonkers NY 10701 (914) 207-2300 false false false false Common Stock, $0.0001 par value per share CFRX false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 1 24 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName, dei:SecurityExchangeName - d464805d8k.htm 7 d464805d8k.htm cfrx-20230208.xsd cfrx-20230208_lab.xml cfrx-20230208_pre.xml d464805dex31.htm http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d464805d8k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 24 }, "contextCount": 1, "dts": { "inline": { "local": [ "d464805d8k.htm" ] }, "labelLink": { "local": [ "cfrx-20230208_lab.xml" ] }, "presentationLink": { "local": [ "cfrx-20230208_pre.xml" ] }, "schema": { "local": [ "cfrx-20230208.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd" ] } }, "elementCount": 25, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 5, "total": 5 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 0, "nsprefix": "cfrx", "nsuri": "http://www.contrafect.com/20230208", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d464805d8k.htm", "contextRef": "duration_2023-02-08_to_2023-02-08", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d464805d8k.htm", "contextRef": "duration_2023-02-08_to_2023-02-08", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.contrafect.com//20230208/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0001193125-23-039351-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-039351-xbrl.zip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end